Navigation Links
Multiple species of bacteria may cause trachoma: Implications for treatment

In a study published in this weeks PLoS Medicine, researchers have found that more than one species of bacteria may be causing the infectious eye disease trachoma. Six million people most of whom live in crowded and unhygienic conditions in the developing world are blind because of the disease and many more are actively infected. The possibility that multiple strains of the Chlamydiceae family of bacteria are involved in trachoma would involve a re-evaluation of vaccines and treatment programmes.

It is accepted that Chlamydia trachomatis (C. trachomatis) causes trachoma. The bacteria, some strains of which are associated with sexually transmitted infections, can also pass between people on hands and clothing; successive infections cause scarring of the inside of the eyelid. As the eyelashes of the infected eyes turn inward they scar the cornea - the transparent tissue covering the front of the eye - leading eventually to blindness. To investigate whether other species of Chlamydiceae also cause human trachoma, Deborah Dean and colleagues from Childrens Hospital Oakland Research Institute and the University of California San Francisco conducted their research in the Lumbini Zone of south-western Nepal where the disease is endemic. Obtaining specimens from 146 individuals in 9 households, they found that a third of the people who had trachoma were infected with only C. trachomatis, including not only the type that is typically described in trachoma-infected eyes but also the type usually associated with sexually transmitted diseases. Also, participants with Chlamidiacae infections of the eye were infected only with species previously associated with lung infections: one in five showed Chlamydophilia psittaci (C. psittaci) and one in ten Chlamydophila pneumoniae (C. pneumoniae); infection with these strains was just as strongly linked with severe inflammation of the eyes as was infection with the C. trachomatis bacteria already known to cause tr

Contact: Andrew Hyde
Public Library of Science

Page: 1 2

Related biology news :

1. Diverse genetic abnormalities lead to NF-κB activation in multiple myeloma
2. Nicotinic receptors may be important targets for treatment of multiple addictions
3. Emphasis on conifer forests places multiple species at risk
4. For honey bee queens, multiple mating makes a difference
5. Israeli scientists identify: Genes that affect responses of multiple sclerosis patients to copaxone
6. New magnetic separation technique might detect multiple pathogens at once
7. The power of multiples: Connecting wind farms can make a more reliable - and cheaper - power source
8. New continent and species discovered in Atlantic study
9. One species entire genome discovered inside anothers
10. How the plant immune system can drive the formation of new species
11. Student study bolsters case for adding a rare sunflower to the endangered species list
Post Your Comments:
(Date:9/30/2015)... , Sept. 30, 2015  The global glucose monitoring device ... 2015. So says a new report on the industry from ... segment dominate the market, followed by continuous glucose monitoring and ... on the market for these products in its latest report, ... , ...
(Date:9/28/2015)... , Sept. 28, 2015 ... today that its expedited traveler service is ... platform transforms travel, bringing a frictionless experience, ... members. "CLEAR offers our travelers ... customer service," said Jim Smith , ...
(Date:9/28/2015)... , September 28, 2015 ... Component (Hardware & Software), Product (Scanner & Others), Application ... & Defense, & Others) & Geography Global - Forecast ... expected to reach USD 3627.90 Million by 2020, at ... Browse 65 market data T ables ...
Breaking Biology News(10 mins):
... and Nanosystems Research (IBN), Austrian Academy of Sciences ... of Technology, Cambridge, USA report the study of ... Designer Lipid-Like Peptide Surfactants” in the May 30th ... Their findings not only help us to ...
... a chronic and progressive lung disorder from which most patients ... by the insidious onset of dyspnea or cough and usually ... coworkers present in an article published in the online, open-access ... that a subset of IPF patients has a short duration ...
... chronic lung disease typically characterized by the slow but ... patients live about five years after diagnosis. However, according ... online journal PLoS ONE, a subset of patients with ... progression to complete pulmonary failure and death without a ...
Cached Biology News:
(Date:10/9/2015)...  Pulmatrix, Inc., (NASDAQ: PULM ) will be webcasting ... th Annual BIO Investor Forum on Tuesday, ... --> th Annual BIO Investor Forum ... pm EDT). --> Pulmatrix will be presenting ... on Thursday, October 15, 2015 at 8:30 am EDT. Additionally, ...
(Date:10/8/2015)... SAN DIEGO , Oct. 8, 2015 /PRNewswire/ ... oncology company developing new treatments for cancer and ... Chief Executive Officer, will be presenting at the ... Las Vegas :Event:Aegis Capital Corporation 2015 ... PDTLocation:Brahms 2 room, The Encore @ The Wynn ...
(Date:10/8/2015)... 2015 .   ... Goldman Small Cap Research, a stock market ... microcap sectors, announced today that it has published ... Inc. (OTCQB - PMCB), a publicly traded, clinical ... treatments for cancer and diabetes. To view the ...
(Date:10/8/2015)... 2015 /PRNewswire/ - RepliCel Life Sciences Inc. (OTCQB: REPCF) (TSX.V: ... the development of autologous cell therapies, today announced its schedule ... place in the month of October: Stem ... RepliCel will be presenting at the annual Partnering Forum, ... to be held October 7-9 in La ...
Breaking Biology Technology:
... sole U.S. supplier of 3M electrosurgical grounding pads ... ... Industries, Inc. and,3M Health Care announce an exclusive license and supply ... agreement,Medline has acquired the exclusive license and sales rights in the ...
... Eastern Time Today, GAITHERSBURG, Md., March 6 ... and corporate progress for,the full year ended December 31, ... further demonstrated that Iomai,s,vaccine and immunostimulant patches can be ... chief executive officer,of Iomai. "This lays the foundation for ...
... (Pink Sheets: VXGN), a biopharmaceutical company, today reported its,year ... a view to,ensuring that stockholders have the most current ... with Raven biotechnologies,inc. VaxGen,s Board of Directors has set ... of Stockholders to vote on the proposed merger., ...
Cached Biology Technology: